210 related articles for article (PubMed ID: 28427176)
21. Choroidal Infiltration as First Clinical Manifestation of T-cell Large Granular Lymphocyte (T-LGL) Leukemia.
Sarny S; Beham-Schmid C; El-Shabrawi Y
Ocul Immunol Inflamm; 2020 Oct; 28(7):1133-1135. PubMed ID: 31577464
[No Abstract] [Full Text] [Related]
22. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
23. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian HM; O'Brien S; Smith TL; Cortes J; Giles FJ; Beran M; Pierce S; Huh Y; Andreeff M; Koller C; Ha CS; Keating MJ; Murphy S; Freireich EJ
J Clin Oncol; 2000 Feb; 18(3):547-61. PubMed ID: 10653870
[TBL] [Abstract][Full Text] [Related]
24. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
[TBL] [Abstract][Full Text] [Related]
25. Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report.
Krackeler ML; Broome C; Lai C
Stem Cell Investig; 2020; 7():24. PubMed ID: 33437844
[TBL] [Abstract][Full Text] [Related]
26. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?
Ok CY; Yin CC; Yabe M; Bueso-Ramos CE; Miranda RN; Medeiros LJ; Konoplev SN
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e95-e100. PubMed ID: 24524924
[No Abstract] [Full Text] [Related]
28. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
30. T-cell receptor gammadelta-large granular lymphocytic leukemia associated with an aberrant phenotype and TCR-Vbeta20 clonality.
Vartholomatos G; Alymara V; Dova L; Kolaitis N; Bourantas KL
Haematologica; 2004 May; 89(5):ECR16. PubMed ID: 15136245
[TBL] [Abstract][Full Text] [Related]
31. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
[TBL] [Abstract][Full Text] [Related]
32. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Lee EJ; Petroni GR; Schiffer CA; Freter CE; Johnson JL; Barcos M; Frizzera G; Bloomfield CD; Peterson BA
J Clin Oncol; 2001 Oct; 19(20):4014-22. PubMed ID: 11600602
[TBL] [Abstract][Full Text] [Related]
33. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Pullen J; Boyett J; Shuster J; Crist W; Land V; Frankel L; Iyer R; Backstrom L; van Eys J; Harris M
J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia.
Anoop P; Ravindranathan G; Osuji N; Dearden CE; Wotherspoon A; Bain BJ; Matutes E
Br J Haematol; 2010 Jan; 148(2):337-9. PubMed ID: 19804452
[No Abstract] [Full Text] [Related]
35. Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
Ruan J; Martin P; Coleman M; Furman RR; Cheung K; Faye A; Elstrom R; Lachs M; Hajjar KA; Leonard JP
Cancer; 2010 Jun; 116(11):2655-64. PubMed ID: 20235190
[TBL] [Abstract][Full Text] [Related]
36. How I treat LGL leukemia.
Lamy T; Loughran TP
Blood; 2011 Mar; 117(10):2764-74. PubMed ID: 21190991
[TBL] [Abstract][Full Text] [Related]
37. A case of CD4(+)T-cell large granular lymphocytic leukemia.
Kim J; Park CJ; Jang S; Cho YU; Park SH; Seo EJ; Chi HS; Suh C
Ann Lab Med; 2013 May; 33(3):196-9. PubMed ID: 23667847
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
[TBL] [Abstract][Full Text] [Related]
39. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
40. [Paraplegia following intrathecal chemotherapy].
Beretta F; Sanna P; Ghielmini M; Marini G; Cavalli F
Schweiz Med Wochenschr; 1996 Jun; 126(25):1107-11. PubMed ID: 8711459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
